What 1843 Capital does

1843 Capital is a privately held, early-stage venture capital firm founded in 2016 by Tracy Killoren Chadwell and headquartered between Washington, DC and New York, NY. The firm invests in AgeTech and Longevity — technology companies serving older adults, their caregivers, and the broader 50+ health economy — and describes its value-add as "capital, counsel, and connectivity." The portfolio spans virtual care platforms (Midi Health for women's midlife hormonal health, Rippl for senior mental health), caregiver support tools (Cariloop, Tender, and formerly Kinto), diagnostic platforms (Function Health, Pluto Health), transportation and mobility (HopSkipDrive, May Mobility), smart-home aging-in-place devices (Lotus Ring), digital health and navigation (Manta Cares, Recuro Health), and one digital-asset bank (Custodia Bank), with selected non-aging generalist positions (Bishop Fox, Corsha, Enveil).

The business model follows standard emerging-manager VC economics: 1843 Capital raises capital from undisclosed Limited Partners and deploys it via direct equity investments in early-stage rounds. Revenue is generated through management fees on committed capital and carried interest on successful exits; specific fund terms are not publicly disclosed. The firm does not develop proprietary technology. Its go-to-market is community-led and ecosystem-driven: deal flow is sourced through the AARP Age Collective (where Founding Partner Tracy Chadwell holds a board seat), NIH/NIA accelerators, and Springboard programs, supplemented by industry-conference presence (Milken, TEDx, MIT, US Senate testimony) and earned media (Bloomberg, MSNBC, Forbes, Entrepreneur Magazine). The team of five named members — Founding Partner Tracy Chadwell, Partner & CFO Gwen Weiss, Venture Partners Sharon Rodriguez and Brian Geyser, and Executive Advisor Larry Flanagan (former MasterCard Global CMO and AARP Services President & CEO) — claims 100+ years of combined investing, marketing, and operational experience, which is the firm's central pitch to founders and LPs in a thematic niche most generalist VCs underweight.

Name

1843 Capital

Legal name

1843 Capital

Website

https://1843capital.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

1843 Capital is an early-stage venture capital firm founded in 2016 that invests in AgeTech and Longevity startups, providing capital, strategic counsel, and ecosystem connectivity to founders serving the 50+ health and aging economy.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industry

Venture Capital Fundraising Placement (FSAEALAC)

Keywords

• Venture capital investing
• Early-stage equity funding
• AgeTech investments
• Longevity sector investing
• Portfolio investment management

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Fund Management: 1843 Capital generates returns through traditional VC fund economics including management fees on committed capital and carried interest (performance fees) on successful portfolio company exits.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

1843 Capital is an early-stage venture capital firm that invests in AgeTech and Longevity companies. The firm provides capital, strategic counsel, and connectivity (industry introductions, operational expertise) to founders building technology companies addressing aging, older adult care, and longevity. Returns are generated through traditional VC fund economics including management fees on committed capital and carried interest on portfolio exits.

Product overview

1843 Capital is an early-stage venture capital firm founded in 2016, specializing in AgeTech and Longevity investments. The firm does not offer a unified product but has built a diversified portfolio of portfolio companies addressing aging, healthcare, and longevity markets. The portfolio spans virtual care platforms (Midi Health for women's midlife health, Rippl for senior mental health), caregiver support tools (Cariloop, Tender, Kinto), diagnostic platforms (Function Health, Pluto Health), transportation (HopSkipDrive, May Mobility), smart home devices (Lotus Ring), digital health (Manta Cares, Recuro Health), and digital banking (Custodia Bank). Several products have been acquired: Kinto was acquired by Rippl, while others have achieved successful exits including Beautycounter, Tempo Automation, Artemis (acquired by iUNU), Finn (acquired by Glia), IOTAS (acquired by ADT), Sagely (acquired by Hemp Fusion Wellness), and Keen (acquired by Connie Health).

Differentiator

Problem solved

Functional benefit

Products and services

• Early-Stage Venture Capital Investment Direct equity investments in early-stage AgeTech and Longevity companies, typically leading or participating in funding rounds. Includes post-investment strategic counsel, operational expertise, and connectivity through the firm's network in aging, healthcare, and longevity ecosystems. Targeted at founders building technology companies for older adults and their caregivers.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• AARP Age CollectivecoreStrategic or Co-development Partner1843 Capital participates in the AARP Age Collective, an ecosystem supporting AgeTech entrepreneurs. Founding Partner Tracy Chadwell serves on this board, connecting the firm to AARP's resources and network in the aging space.
• National Institute on Aging / NIHminorStrategic or Co-development Partner1843 Capital connects with AgeTech startups through NIH/NIA accelerator programs and startup challenges, sourcing deal flow and supporting entrepreneurs in the aging innovation ecosystem.
• SpringboardminorStrategic or Co-development PartnerVenture Partner Sharon Rodriguez serves as advisor and mentor to early stage founders through Springboard's accelerator programs focused on women-led ventures.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Primetime Partners: A venture firm focused on companies serving the 50+ consumer and aging economy; a direct competitor to 1843 Capital in early-stage AgeTech investing with overlapping LPs and portfolio themes.
• Generator Ventures: An early- and growth-stage venture fund investing exclusively in AgeTech, senior care, and longevity; competes head-to-head with 1843 Capital for the same founder pool and LP capital.
• Ziegler Link•Age Funds: Long-standing AgeTech-focused investment platform that has backed senior living, healthcare technology, and aging services, overlapping with 1843's thesis and target market.
• W Health Ventures: Boston-based early-stage VC focused on AgeTech, digital health, and behavioral health for older adults; directly comparable mandate and portfolio overlap with 1843.
• StartUp Health: A health-focused moonshots venture platform and fund running a global accelerator for health and longevity founders; overlaps with 1843 on early-stage deal flow and LP base.

Emerging players

• BoldAge Ventures: Early-stage AgeTech fund co-founded by aging-industry veterans; competes with 1843 in seed/Series A AgeTech deals with a slightly narrower senior-care focus.
• King River Capital: Early-stage investor with thesis overlap in healthspan, longevity, and consumer health; comparable stage and check size though broader sector mandate than 1843.

Broad incumbents

• Andreessen Horowitz (a16z Bio + Health): Mega-VC with a dedicated bio/health team increasingly active in digital health, women's health, and aging-adjacent categories; competes with 1843 for breakout rounds at the Series B+ level.
• General Catalyst: Large multi-stage venture firm with a Health Assurance thesis that touches digital health, care delivery, and aging; competes with 1843 in later rounds and co-invests in 1843-backed companies.
• Sequoia Capital: Premier generalist venture firm increasingly active in healthcare, fintech (Custodia-relevant), and consumer health; competes for category-defining companies in 1843's portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/1843-capital
• Xx.com/1843capital

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments14 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 1843 Capital